Matin Shahriar 4

What Happened

• Matin Shahriar, a director of KORU Medical Systems, Inc. (KRMD), was granted/received 3,472 shares on 2026-04-01. The filing shows an acquisition price of $4.32 per share, for a total value of $14,999. The transaction is reported as an award/grant (transaction code A), not an open-market purchase.

Key Details

• Transaction date: 2026-04-01
• Price per share: $4.32; Total value reported: $14,999
• Transaction type/code: Award/Grant (A) — shares were acquired as an award, likely part of compensation
• Shares owned after transaction: Not specified in this Form 4
• Filing remarks: The filer included a statement disclaiming that this filing constitutes admission of beneficial ownership; a Power of Attorney has been previously filed

Context

• Awards/grants typically reflect compensation and may be subject to vesting or other restrictions; they are not the same as an insider buying shares on the open market and do not necessarily signal the insider's current market view.
• The reported value (~$15k) is modest for an insider award; retail investors should treat this as a compensation-related grant unless additional details (vesting, restrictions) are disclosed in other filings.